Capsulution: US Patent granted for the Production of Nanocapsules
With the granting of a further US patent, Capsulution has successfully extended its worldwide patent protection. The recently granted patent (US 7,101,575) is a basis patent for the production of nanocapsules according to the so-called LBL Technology®.
According to the company, the LBL Technology® (Layer-by-Layer) is the source for a host of products and solutions within the life-science industry. Accordingly, the experts from Capsulution can endow the nanocapsules with special pharmaceutical, biochemical, electric, optical or magnetic properties and thus render them indispensable aids in many areas of life and science.
"The newly granted patent ensures our competitive advantage as one of the leading developers of nano and microcapsules in the field of modern life-science applications. We can pass this safeguard on to our customers who appreciate an outstanding and qualitatively high development performance from us," says Alexander Herrmann, CFO of Capsulution.
Other news from the department research and development
![Newsletter](https://img.chemie.de/assets/ceurope/images/newsletter.png)
Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.